Electromedical Technologies(EMED)
$0.000.00 (0.00%)
EMED
Electromedical Technologies financials statements
$0.00
At close:0.00 (0.00%)
Want to see EMED full AI Analyst Report?
Electromedical Technologies (EMED) Ratios
24 Followers
Electromedical Technologies Ratios
EMED's free cash flow for Q2 2026 was $-116.22K. For the 2026 fiscal year, EMED's free cash flow was increased by $0.00 and operating cash flow was $-116.22K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.16 | 0.07 | 0.13 | 0.22 | 0.47 |
| Quick Ratio | 0.16 | 0.06 | 0.11 | 0.20 | 0.32 |
| Cash Ratio | 0.10 | 0.00 | 0.03 | 0.13 | 0.27 |
| Solvency Ratio | -0.30 | -0.28 | -0.72 | -0.96 | -3.98 |
| Operating Cash Flow Ratio | -0.03 | -0.03 | -0.42 | -0.26 | -0.83 |
| Short-Term Operating Cash Flow Coverage | -0.14 | -0.08 | -1.02 | -0.58 | -1.33 |
| Net Current Asset Value | $ -3.77M | $ -4.09M | $ -3.17M | $ -2.93M | $ -1.45M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.44 | 2.98 | 2.27 | 1.46 | 1.12 |
| Debt-to-Equity Ratio | -0.34 | -0.41 | -0.59 | -0.89 | -2.18 |
| Debt-to-Capital Ratio | -0.52 | -0.70 | -1.45 | -8.09 | 1.85 |
| Long-Term Debt-to-Capital Ratio | -0.04 | -0.04 | -0.06 | -0.40 | -13.68 |
| Financial Leverage Ratio | -0.24 | -0.14 | -0.26 | -0.61 | -1.94 |
| Debt Service Coverage Ratio | -0.73 | -0.63 | -0.75 | -1.25 | -1.22 |
| Interest Coverage Ratio | -6.19 | -4.62 | -2.31 | -2.03 | -1.15 |
| Debt to Market Cap | 2.12 | 5.88 | 5.85 | 2.21 | 0.46 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.10 |
| Net Debt to EBITDA | -0.88 | -1.54 | -0.94 | -0.61 | -0.23 |
| Profitability Margins | |||||
| Gross Profit Margin | -150.94% | 64.79% | 77.51% | 77.28% | 78.04% |
| EBIT Margin | -2468.71% | -180.40% | -129.60% | -232.85% | -569.38% |
| EBITDA Margin | -2223.35% | -172.17% | -127.66% | -230.95% | -566.96% |
| Operating Profit Margin | -2468.71% | -180.99% | -153.09% | -139.46% | -418.83% |
| Pretax Profit Margin | -3495.26% | -219.58% | -195.82% | -301.65% | -934.59% |
| Net Profit Margin | -3495.26% | -219.58% | -195.82% | -301.65% | -934.59% |
| Continuous Operations Profit Margin | -3495.26% | -219.58% | -195.82% | -301.65% | -934.59% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 141.58% | 121.32% | 127.91% | 216.30% | 223.15% |
| Return on Assets (ROA) | -167.32% | -244.12% | -352.93% | -256.30% | -604.81% |
| Return on Equity (ROE) | 39.80% | 33.65% | 91.94% | 156.18% | 1173.72% |
| Return on Capital Employed (ROCE) | 29.33% | 29.34% | 79.17% | 102.08% | 9486.90% |
| Return on Invested Capital (ROIC) | 42.78% | 47.08% | 177.12% | 684.75% | -442.40% |
| Return on Tangible Assets | -167.32% | -244.12% | -352.93% | -256.30% | -604.81% |
| Earnings Yield | -246.00% | -497.93% | -1000.28% | -387.50% | -248.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.55 | 156.48 | 306.62 | 121.75 | 25.86 |
| Payables Turnover | 0.19 | 0.70 | 1.27 | 0.98 | 0.93 |
| Inventory Turnover | 4.91 | 9.97 | 4.43 | 4.21 | 0.91 |
| Fixed Asset Turnover | 0.28 | 2.35 | 4.51 | 1.63 | 1.25 |
| Asset Turnover | 0.05 | 1.11 | 1.80 | 0.85 | 0.65 |
| Working Capital Turnover Ratio | -0.01 | -0.17 | -0.52 | -0.76 | -0.85 |
| Cash Conversion Cycle | -1713.89 | -482.42 | -204.55 | -283.02 | 20.94 |
| Days of Sales Outstanding | 102.91 | 2.33 | 1.19 | 3.00 | 14.11 |
| Days of Inventory Outstanding | 74.36 | 36.62 | 82.45 | 86.72 | 400.31 |
| Days of Payables Outstanding | 1891.16 | 521.37 | 288.20 | 372.74 | 393.49 |
| Operating Cycle | 177.27 | 38.95 | 83.64 | 89.72 | 414.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -49779.00 | -37439.00 | -9.47 | -257779.00 | -397896.00 |
| Capital Expenditure Coverage Ratio | -49779.00 | -37439.00 | -9.47 | -257779.00 | -397896.00 |
| Operating Cash Flow Coverage Ratio | -0.12 | -0.07 | -0.83 | -0.39 | -0.76 |
| Operating Cash Flow to Sales Ratio | -3.63 | -0.19 | -1.05 | -0.67 | -1.32 |
| Free Cash Flow Yield | -25.51% | -43.29% | -593.48% | -86.40% | -34.94% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.41 | -0.20 | -0.10 | -0.26 | -0.40 |
| Price-to-Sales (P/S) Ratio | 14.21 | 0.44 | 0.20 | 0.78 | 3.77 |
| Price-to-Book (P/B) Ratio | -0.16 | -0.07 | -0.09 | -0.40 | -4.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.92 | -2.31 | -0.17 | -1.16 | -2.86 |
| Price-to-Operating Cash Flow Ratio | -3.92 | -2.31 | -0.19 | -1.16 | -2.86 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Enterprise Value Multiple | -1.52 | -1.80 | -1.09 | -0.94 | -0.90 |
| Enterprise Value | 1.39M | 1.82M | 1.87M | 2.50M | 4.61M |
| EV to EBITDA | -1.52 | -1.80 | -1.09 | -0.94 | -0.90 |
| EV to Sales | 33.75 | 3.10 | 1.39 | 2.18 | 5.08 |
| EV to Free Cash Flow | -9.31 | -16.24 | -1.20 | -3.24 | -3.86 |
| EV to Operating Cash Flow | -9.31 | -16.24 | -1.32 | -3.24 | -3.86 |
| Tangible Book Value Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| Shareholders’ Equity Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Net Income Per Share | -0.00 | -0.00 | -0.01 | -0.03 | -0.17 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.42 | 1.22 | 1.51 | 1.30 | 1.64 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.17 | 0.08 | 0.24 |
| SG&A to Revenue | 23.18 | 2.46 | 1.67 | 1.66 | 4.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.53 | 0.44 | 2.90 |
| Income Quality | 0.10 | 0.09 | 0.54 | 0.22 | 0.14 |
Currency in USD
